— Turbine has successfully completed the first phase of its oncology target identification and validation collaboration with Ono ...
Business Wire
|
September 12, 2024
Zug, Switzerland-based SkyCell, a company transforming the pharmaceutical supply chain, announced on Tuesday that it has closed $116M ...
Vigneshwar Ravichandran
June 25, 2024
SAN DIEGO–(BUSINESS WIRE)–#AI–Scientist.com, the world’s leading marketplace for biopharma research, today announced the launch of a new large ...
June 19, 2024
SEOUL, South Korea–(BUSINESS WIRE)–#AI—Oncocross, a Seoul-based AI drug discovery and development biotech, announced on May 22nd that it ...
May 27, 2024
CANTON, Mich. & LONDON–(BUSINESS WIRE)– With extended drug development experience, Zee helps to guide the statistical programming team ...
April 4, 2024
Geelan, the Netherlands-based Matisse Pharmaceuticals, a clinical-stage company developing a medicinal product for sepsis, announced on Thursday, that ...
January 4, 2024
Zurich-based SkyCell, a technology company that aims to revolutionise global pharmaceutical logistics, announced that it has secured $57M ...
Vishal Singh
October 31, 2023
Tagworks Pharmaceuticals is a precision medicine firm that is utilising its technological platform covered by a large patent portfolio to produce a new standard of care for patients suffering from serious illnesses such as cancer.
June 26, 2023
Xinvento is a biotech company focused on developing therapies for congenital hyperinsulinism (CHI).
March 2, 2023
Tübingen, Germany-based CureVac, a biopharmaceutical company developing transformative medicines based on mRNA, announced on Tuesday, February 7, the ...
Editorial team
February 9, 2023
Dublin-based healthcare group Uniphar, announced on Monday, that it has acquired the Netherlands-based BModesto, a healthcare services company, ...
Atish Rajasekharan
November 22, 2022
Xeltis has developed a polymer-based restorative device for cardiovascular treatment.
August 9, 2022
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
10 years of Dutch Startup Visa dreams: A look back with Denis Chernobaev